The FDA has refused to initiate the approval process for Moderna's mRNA-1010 flu vaccine. A US government spokesperson alleged that Moderna's clinical trial exposed participants to an increased risk of severe illness, leading the FDA to decline considering the vaccine for approval. The reasons for the FDA's decision and the details of the alleged safety concerns are unclear from the provided information.